Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition
Hanadi Ajam Oughli, Marie Anne Gebara, Adam Ciarleglio, Helen Lavretsky, Patrick J. Brown, Alastair J. Flint, Nuri B. Farber, Jordan F. Karp, Benoit H. Mulsant, Charles F. Reynolds, Steven P. Roose, Lei Yang, Meryl A. Butters, Eric J. Lenze
Dive into the research topics of 'Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition'. Together they form a unique fingerprint.